Class II recall: Baxter Healthcare Corporation: Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg

A Class II recall notice reports that Baxter Healthcare Corporation is recalling its Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL) single-dose GALAXY container, NDC 0338-9549-50. The recall notice cites current Good Manufacturing Practice (CGMP) deviations as the reason for the action.

Most relevant for: Clinicians and facilities using this specific Baxter clindamycin premix injection for parenteral antibiotic administration.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.